Comparison of Bispecific T-Cell Engager Antibodies and CAR-T Therapies for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Systematic Review and Meta-Analysis

Author / 作者群

張淳瑄¹,謝秉軒¹,陳昱光²

Affiliation / 服務單位

1. Graduate Institute of Pharmacy, National Defense Medical University, Taipei City, Taiwan
2. Department of Hematology-Oncology, Tri-Service General Hospital, Taipei City, Taiwan

Back to list